Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...

The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...

The Leukemia & Lymphoma Society, the largest nonprofit dedicated to ending blood cancer, visits the Nasdaq MarketSite in Times Square to culminate its 75th year and launch a bold goal for the ...

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments ...

The NI Synchronization Custom Device is licensed under an MIT-style license (see LICENSE). Other incorporated projects may be licensed under different licenses. All licenses allow for non-commercial ...

Red warnings for wind have been issued for all 26 counties in the Republic of Ireland A red wind warning has been issued for the whole of the Republic of Ireland, with Met Éireann warning of a ...

The light blue cluster centers on the treatment of acute leukemia, featuring keywords such as “imatinib,” “inhibitor,” “lymphoma,” “nilotinib,” and “therapy.” This clustering of keywords helps ...

The finance minister has called for clarity around funding to cover the increase in employers' National Insurance contributions from April. Since the Budget last October, Caoimhe Archibald has ...

Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes following glucarpidase treatment. Patients with lymphoma or leukemia involving the ...